Recent Updates
Recently added Catalysts
BIIB

Biogen 2015 Revenues Increase 11% to $10.8 Billion

Key Takeaway: Biogen 2015 Revenues Increase 11% to $10.8 Billion

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis

Full Press Release Details

Biogen 2015 Revenues Increase 11% to $10.8 Billion.
Last updated: Jan 27, 2016